A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein

E Ellen Van Damme P Pravien Abeywickrema Y Yanting Yin J Jiexiong Xie S Sofie Jacobs M Mandeep Kaur Mann J Jordi Doijen R Robyn Miller M Madison Piassek S Simone Marsili M Murali Subramanian L Leah Gottlieb R Rana Abdelnabi M Michiel Van Gool N Nick Van den Broeck I Ines De Pauw A Annick Diels P Peter Vermeulen K Koen Temmerman T Trevor Scobey M Melissa Mattocks A Alexandra Schäfer D Dirk Jochmans S Steven De Jonghe P Pieter Leyssen W Winston Chiu M Mayra Diosa Toro M Marleen Zwaagstra A Anouk A. Leijs H Heidi L. M. De Gruyter C Christophe Buyck K Klaas Van Den Heede F Frank Jacobs C Christel Van den Eynde L Laura Thijs V Valerie Raeymaekers S Seth Miller A Amanda Del Rosario J Johan Neyts D Danielle Peeters R Ralph S. Baric F Frank J. M. van Kuppeveld E Eric J. Snijder M Martijn J. van Hemert M Mario Monshouwer S Sujata Sharma R Ruxandra Draghia-Akli A Anil Koul M Marnix van Loock

Abstract

Abstract The membrane (M) protein of betacoronaviruses is well conserved and has a key role in viral assembly 1,2 . Here we describe the identification of JNJ-9676, a small-molecule inhibitor targeting the coronavirus M protein. JNJ-9676 demonstrates in vitro nanomolar antiviral activity against SARS-CoV-2, SARS-CoV and sarbecovirus strains from bat and pangolin zoonotic origin. Using cryogenic electron microscopy (cryo-EM), we determined a binding pocket of JNJ-9676 formed by the transmembrane domains of the M protein dimer. Compound binding stabilized the M protein dimer in an altered conformational state between its long and short forms, preventing the release of infectious virus. In a pre-exposure Syrian golden hamster model, JNJ-9676 (25 mg per kg twice per day) showed excellent efficacy, illustrated by a significant reduction in viral load and infectious virus in the lung by 3.5 and 4 log 10 -transformed RNA copies and 50% tissue culture infective dose (TCID 50 ) per mg lung, respectively. Histopathology scores at this dose were reduced to the baseline. In a post-exposure hamster model, JNJ-9676 was efficacious at 75 mg per kg twice per day even when added at 48 h after infection, when peak viral loads were observed. The M protein is an attractive antiviral target to block coronavirus replication, and JNJ-9676 represents an interesting chemical series towards identifying clinical candidates addressing the current and future coronavirus pandemics.

Article Details

Journal Nature
Volume / Issue Vol. 640, Issue 8058
Published April 10, 2025
Pages 506-513
ISSN 0028-0836
Publisher Nature Portfolio

Journal Info

Nature

Nature Portfolio

ISSN: 0028-0836 Health Sciences

Authors (49)

E

Ellen Van Damme

P

Pravien Abeywickrema

Y

Yanting Yin

J

Jiexiong Xie

S

Sofie Jacobs

M

Mandeep Kaur Mann

J

Jordi Doijen

R

Robyn Miller

M

Madison Piassek

S

Simone Marsili

M

Murali Subramanian

L

Leah Gottlieb

R

Rana Abdelnabi

M

Michiel Van Gool

N

Nick Van den Broeck

I

Ines De Pauw

A

Annick Diels

P

Peter Vermeulen

K

Koen Temmerman

T

Trevor Scobey

M

Melissa Mattocks

A

Alexandra Schäfer

D

Dirk Jochmans

S

Steven De Jonghe

P

Pieter Leyssen

W

Winston Chiu

M

Mayra Diosa Toro

M

Marleen Zwaagstra

A

Anouk A. Leijs

H

Heidi L. M. De Gruyter

C

Christophe Buyck

K

Klaas Van Den Heede

F

Frank Jacobs

C

Christel Van den Eynde

L

Laura Thijs

V

Valerie Raeymaekers

S

Seth Miller

A

Amanda Del Rosario

J

Johan Neyts

D

Danielle Peeters

R

Ralph S. Baric

F

Frank J. M. van Kuppeveld

E

Eric J. Snijder

M

Martijn J. van Hemert

M

Mario Monshouwer

S

Sujata Sharma

R

Ruxandra Draghia-Akli

A

Anil Koul

M

Marnix van Loock